EUDA Health Holdings Limited filed a Form 6-K on November 3, 2026, reporting the results of its October 30, 2026 Extraordinary General Meeting at which shareholders approved a dual-class share reclassification and amended articles of association.

Key Highlights

  • Record date shares: 2,994,325 Ordinary Shares were issued, outstanding, and entitled to vote as of October 8, 2026.
  • Quorum reached: 2,088,134 Ordinary Shares were voted in person or by proxy, representing 69.74% of total eligible votes.
  • All three proposals approved: Each proposal presented at the meeting received shareholder approval.
  • Dual-class structure created: The company authorized an unlimited number of Class A ordinary shares and 2,000,000 Class B ordinary shares, both with no par value.
  • Reclassification of founder shares: 437,824 shares held by Tan Meng Dong and his affiliate were redesignated as Class B ordinary shares; 2,556,501 remaining outstanding shares became Class A ordinary shares.
  • Amended M&A effective immediately: The amended and restated memorandum and articles of association were filed with the Registrar of Corporate Affairs in the British Virgin Islands on October 30, 2026, and became effective upon filing.

EUDA Health Holdings Reclassifies Share Structure Following October 2026 EGM

According to the filing, EUDA Health Holdings Limited (NASDAQ:EUDA) held its 2026 Extraordinary General Meeting on October 30, 2026. The company disclosed that three proposals were put to shareholders and all three were approved. The meeting was conducted following a Proxy Statement and Notice filed on a Form 6-K with the SEC on October 13, 2026.

Proposal No. 1, which received 2,086,971 votes in favor, 1,163 against, and 0 abstentions, authorized the creation of a dual-class share structure. Under the reclassification described in the filing, 437,824 shares held by Tan Meng Dong and his affiliate were redesignated as Class B ordinary shares, 1,562,176 authorized but unissued shares were reclassified as authorized but unissued Class B ordinary shares, and the remaining 2,556,501 outstanding shares became Class A ordinary shares. All remaining authorized but unissued shares were designated as Class A ordinary shares.

Proposal No. 2, the adoption of an amended and restated memorandum and articles of association, received 2,086,972 votes in favor, 1,161 against, and 1 abstention. Proposal No. 3, authorizing possible adjournment of the EGM if needed, received 2,086,996 votes in favor, 1,137 against, and 1 abstention. The filing states that shortly after the meeting, the company filed the Amended M&A with the Registrar of Corporate Affairs in the British Virgin Islands, with the document becoming effective immediately upon that filing. The amended articles are included as Exhibit 99.1 to the report. The report was signed by Alfred Lim, Chief Executive Officer, on November 3, 2026.

What Was Disclosed

EUDA Health Holdings Limited reported the results of its October 30, 2026 Extraordinary General Meeting, disclosing shareholder approval of a dual-class share reclassification, adoption of amended articles of association, and authorization of a potential EGM adjournment.